| Workforce | Rates (%) | p-value |
SEX |
| ||
Female | 62 | 35.6 | <0.001 |
Male | 112 | 64.4 | |
TREATMENT |
| ||
Tenofovir | 12 | 24.0 | 0.003 |
Traditional | 3 | 6.0 | |
No treatment | 11 | 22.0 | |
Not specified | 24 | 48.0 | |
Holy subjects (Witnesses) | 124 | 71.26 |